Response to Puder KL,Wood LL,Sherrill A: Health Economics with Retrospective Data: Selection Bias Issues ( Letter to the Editor ). J Int Med Res 1997;25: 45 – 47.

Puder KL Wood LL Sherrill A Health economics with retrospective data: selection bias issues. J Int Med Res 1997; 25: 45–47.

Sclar DA Robison LM Skaer TL Antidepressant pharmacotherapy: economic valuation of fluoxetine, paroxetine, and sertraline in a health maintenance organization. J Int Med Res 1995; 23: 395–412.

Montgomery SA Henry J McDonald G Selective serotonin re-uptake inhibitors: meta-analysis of discontinuation rates. Int Clin Psychopharmacol 1994; 9: 47–53.

Sclar DA Robison LM Skaer TL Antidepressant pharmacotherapy: economic outcomes in a health maintenance organization. Clin Ther 1994; 16: 715–730.

Skaer TL Sclar DA Robison LM Economic valuation of amitriptyline desipramine, nortriptyline, and sertraline in the management of patients with depression. Curr Ther Res 1995; 56: 556–567.

Skaer TL Sclar DA Robison LM Antidepressant pharmacotherapy: effect on women's resource utilization within a health maintenance organization. J Appl Tner 1996; 1: 45–52.

McCombs JS Nichol MB Stimmel GL In the Symposium entitled: Methodological Issues in the Economic Appraisal of Antidepressant Pharmacotherapy. Tenth World Psychiatric Association Meeting. Madrid, Spain, August 23, 1996.

Thompson D Buesching D Gregor KJ Patterns of antidepressant use and their relation to costs of care. Am J Managed Care 1996; 2: 1239–1246.

Simon G Wagner E VonKorff M Cost-effectiveness comparisons using “real world” randomized trials: the case of new antidepressant drugs. J Clin Epidemiol 1995; 48: 363–373.